The combination elexacaftor/tezacaftor/ivacaftor (eti) alters the lipid composition of the lung cells irrespective of CFTR mutation
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2023 Apr 21;S1569-1993(23)00115-7. doi: 10.1016/j.jcf.2023.04.012.
Document
Link
Theme
Keywords
dihydroceramides [4]
lipidomics [5]
sphingolipids [7]
Date
Friday, April 21, 2023
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [9]